Institutional Ownership Terns Pharmaceuticals, Inc. (TERN)
This table provides information about the institutional ownership of Terns Pharmaceuticals, Inc. (TERN). We have compiled data on the 167 institutions that hold shares in the stock, with a total of 78.3 Million shares, which have been reported (via 13F filing form) to have a value of $509 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Rothschild Investment LLC
Chicago, IL |
Oct 18, 2024 Q3 2024 |
110
shares
|
$715
0.0% of portfolio
|
Q3 2024
Added 175.0%
|
|
|
Lindbrook Capital, LLC
|
Nov 01, 2024 Q3 2024 |
63
shares
|
$409
0.0% of portfolio
|
Q3 2024
Added 1.61%
|
|
|
Farther Finance Advisors, LLC
San Francisco, CA |
Oct 28, 2024 Q3 2024 |
27
shares
|
$175
0.0% of portfolio
|
Q2 2024
Reduced 3.57%
|
|
|
Cwm, LLC
|
Oct 08, 2024 Q3 2024 |
24
shares
|
$156
0.0% of portfolio
|
Q3 2024
Added 1100.0%
|
|
|
Capital Performance Advisors LLP
|
Nov 01, 2024 Q3 2024 |
23
shares
|
$149
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|